-
1
-
-
0035960630
-
Global burden of cardiovascular diseases, part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization
-
Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases, part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746-2753
-
(2001)
Circulation
, vol.104
, pp. 2746-2753
-
-
Yusuf, S.1
Reddy, S.2
Ounpuu, S.3
-
2
-
-
3142729178
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
-
National Heart Lung and Blood Institute; American College of Cardiology Foundation; American Heart Association
-
Grundy SM, Cleeman JI, Merz CN, et al., National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-239
-
(2004)
Circulation
, vol.110
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.I.2
Merz, C.N.3
-
3
-
-
41549118416
-
Lipoprotein management in patients with cardiometabolic risk: Consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation
-
Brunzell JD, Davidson M, Furberg CD, et al. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2008; 51: 1512-1524
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 1512-1524
-
-
Brunzell, J.D.1
Davidson, M.2
Furberg, C.D.3
-
4
-
-
2942683422
-
Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyper-lipidemia in coronary artery disease risk
-
Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyper-lipidemia in coronary artery disease risk. J Clin Endocrin Metab 2004; 6: 2601-2607
-
(2004)
J Clin Endocrin Metab
, vol.6
, pp. 2601-2607
-
-
Carr, M.C.1
Brunzell, J.D.2
-
5
-
-
14944342962
-
Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men
-
Simon A, Chironi G, Gariepy J, et al. Differences between markers of atherogenic lipoproteins in predicting high cardiovascular risk and subclinical atherosclerosis in asymptomatic men. Atherosclerosis 2005; 179: 339-344
-
(2005)
Atherosclerosis
, vol.179
, pp. 339-344
-
-
Simon, A.1
Chironi, G.2
Gariepy, J.3
-
6
-
-
34250714459
-
Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study)
-
Frontini MG, Srinivasan SR, Xu JH, et al. Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study). Am J Cardiol 2007; 100: 64-68
-
(2007)
Am J Cardiol
, vol.100
, pp. 64-68
-
-
Frontini, M.G.1
Srinivasan, S.R.2
Xu, J.H.3
-
7
-
-
57749193318
-
Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals
-
Orakzai SH, Nasir K, Blaha M, et al. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis 2009; 202: 289-295
-
(2009)
Atherosclerosis
, vol.202
, pp. 289-295
-
-
Orakzai, S.H.1
Nasir, K.2
Blaha, M.3
-
8
-
-
0035865609
-
Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment
-
Hecht HS, Superko HR, Smith LK, et al. Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment. Am J Cardiol 2001; 87: 406-412
-
(2001)
Am J Cardiol
, vol.87
, pp. 406-412
-
-
Hecht, H.S.1
Superko, H.R.2
Smith, L.K.3
-
9
-
-
0037333159
-
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
-
Sniderman AD, Furberg CD, Keech A, et al. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003; 361: 777-780
-
(2003)
Lancet
, vol.361
, pp. 777-780
-
-
Sniderman, A.D.1
Furberg, C.D.2
Keech, A.3
-
10
-
-
33746218177
-
The apolipoprotein story
-
Sacks FM. The apolipoprotein story. Atheroscler Suppl 2006; 7: 23-27
-
(2006)
Atheroscler Suppl
, vol.7
, pp. 23-27
-
-
Sacks, F.M.1
-
11
-
-
34249654186
-
Prediction of incident diabetes mellitus in middle-aged adults: The Framingham Offspring Study
-
Wilson PW, Meigs JB, Sullivan L, et al. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007; 167: 1068-1074
-
(2007)
Arch Intern Med
, vol.167
, pp. 1068-1074
-
-
Wilson, P.W.1
Meigs, J.B.2
Sullivan, L.3
-
12
-
-
33846422032
-
Obesity and diabetes in the developing world: A growing challenge
-
Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world: a growing challenge. N Engl J Med 2007; 356: 213-215
-
(2007)
N Engl J Med
, vol.356
, pp. 213-215
-
-
Hossain, P.1
Kawar, B.2
El Nahas, M.3
-
13
-
-
0037035456
-
Prevention Conference VI: Diabetes and cardiovascular disease executive summary - Conference proceeding for healthcare professionals from a special writing group of the American Heart Association
-
Grundy SM, Howard B, Smith Jr S, et al. Prevention Conference VI: diabetes and cardiovascular disease executive summary - conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 2002; 105: 2231-2239
-
(2002)
Circulation
, vol.105
, pp. 2231-2239
-
-
Grundy, S.M.1
Howard, B.2
Smith Jr. S3
-
14
-
-
0037035775
-
Prevention Conference VI: Diabetes and cardiovascular disease: Writing Group i - Epidemiology
-
Howard BV, Rodriguez BL, Bennett PH, et al. Prevention Conference VI: diabetes and cardiovascular disease: Writing Group I - epidemiology. Circulation 2002; 105: e132-7
-
(2002)
Circulation
, vol.105
-
-
Howard, B.V.1
Rodriguez, B.L.2
Bennett, P.H.3
-
15
-
-
0035516047
-
Projection of diabetes burden through 2050: Impact of changing demography and disease prevalence in the US
-
Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care 2001; 24: 1936-1940
-
(2001)
Diabetes Care
, vol.24
, pp. 1936-1940
-
-
Boyle, J.P.1
Honeycutt, A.A.2
Narayan, K.M.3
-
16
-
-
38149005627
-
Impact of impaired fasting glucose on cardiovascular disease: The Framingham Heart Study
-
Levitzky YS, Pencina MJ, D'Agostino RB, et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol 2008; 51: 264-270
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 264-270
-
-
Levitzky, Y.S.1
Pencina, M.J.2
D'Agostino, R.B.3
-
17
-
-
0033553188
-
Diabetes and decline in heart disease mortality in US adults
-
GuK, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999; 281: 1291-1297
-
(1999)
JAMA
, vol.281
, pp. 1291-1297
-
-
Guk Cowie, C.C.1
Harris, M.I.2
-
18
-
-
0037965978
-
Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction
-
Norhammar A, Malmberg K, Rydé n L, et al., Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003; 24: 838-844
-
(2003)
Eur Heart J
, vol.24
, pp. 838-844
-
-
Norhammar, A.1
Malmberg, K.2
Ryden, L.3
-
19
-
-
3142738757
-
GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes. the global registry of acute coronary events
-
Franklin K, Goldberg RJ, Spencer F, et al., GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 2004; 164: 1457-1463
-
(2004)
Arch Intern Med
, vol.164
, pp. 1457-1463
-
-
Franklin, K.1
Goldberg, R.J.2
Spencer, F.3
-
20
-
-
0036701017
-
A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey SCA)
-
Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey SCA). Eur Heart J 2002; 23: 1190-1201
-
(2002)
Eur Heart J
, vol.23
, pp. 1190-1201
-
-
Hasdai, D.1
Behar, S.2
Wallentin, L.3
-
21
-
-
0034730110
-
Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry
-
Malmberg K, Yusuf S, Gerstein Hc, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000; 102: 1014-1019
-
(2000)
Circulation
, vol.102
, pp. 1014-1019
-
-
Malmberg, K.1
Yusuf, S.2
Hc, G.3
-
22
-
-
27444443876
-
Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart Lung and Blood Institute Scientific Statement
-
American Heart Association; National Heart Lung and Blood Institute
-
Grundy SM, Cleeman JI, Daniels SR, et al., American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
-
(2005)
Circulation
, vol.112
, pp. 2735-2752
-
-
Grundy, S.M.1
Cleeman, J.I.2
Daniels, S.R.3
-
23
-
-
0037116641
-
Prevalence of the MetS among US adults: Findings from the third National Health and Nutrition Examination Survey
-
Ford ES, Giles WH, Dietz WH. Prevalence of the MetS among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359
-
(2002)
JAMA
, vol.287
, pp. 356-359
-
-
Ford, E.S.1
Giles, W.H.2
Dietz, W.H.3
-
24
-
-
33846970555
-
Metabolic syndrome: A multiplex cardiovascular risk factor
-
Grundy SM. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007; 92: 399-404
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 399-404
-
-
Grundy, S.M.1
-
25
-
-
0037463608
-
The MetS: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994
-
Park YW, Zhu S, Palaniappan L, et al. The MetS: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163: 427-436
-
(2003)
Arch Intern Med
, vol.163
, pp. 427-436
-
-
Park, Y.W.1
Zhu, S.2
Palaniappan, L.3
-
26
-
-
0036558732
-
Abdominal obesity is associated with increased risk of acute coronary events in men
-
Lakka HM, Lakka TA, Tuomilehto J, et al. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J 2002; 23: 706-713
-
(2002)
Eur Heart J
, vol.23
, pp. 706-713
-
-
Lakka, H.M.1
Lakka, T.A.2
Tuomilehto, J.3
-
27
-
-
34249650811
-
Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes
-
Ingelsson E, Sullivan LM, Murabito JM, et al. Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes. Diabetes 2007; 56: 1718-1726
-
(2007)
Diabetes
, vol.56
, pp. 1718-1726
-
-
Ingelsson, E.1
Sullivan, L.M.2
Murabito, J.M.3
-
28
-
-
33846365989
-
Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies
-
Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007; 49: 403-414
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 403-414
-
-
Gami, A.S.1
Witt, B.J.2
Howard, D.E.3
-
29
-
-
34447309619
-
Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)
-
Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007; 116: 151-157
-
(2007)
Circulation
, vol.116
, pp. 151-157
-
-
Barr, E.L.1
Zimmet, P.Z.2
Welborn, T.A.3
-
30
-
-
33845881411
-
Mechanisms linking obesity to insulin resistance and type 2 diabetes
-
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444: 840-846
-
(2006)
Nature
, vol.444
, pp. 840-846
-
-
Kahn, S.E.1
Hull, R.L.2
Utzschneider, K.M.3
-
31
-
-
0348162332
-
Insulin resistance: From benign to type 2 diabetes mellitus
-
Goldstein BJ. Insulin resistance: from benign to type 2 diabetes mellitus. Rev Cardiovasc Med 2003; 4 Suppl. 6: S3-10
-
(2003)
Rev Cardiovasc Med
, vol.4
, Issue.SUPPL. 6
-
-
Goldstein, B.J.1
-
32
-
-
64749100502
-
Patterns of abdominal fat distribution: The Framingham Heart Study
-
Pou KM, Massaro JM, Hoffmann U, et al. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care 2009; 32 (3): 481-485
-
(2009)
Diabetes Care
, vol.32
, Issue.3
, pp. 481-485
-
-
Pou, K.M.1
Massaro, J.M.2
Hoffmann, U.3
-
33
-
-
34347351228
-
Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study
-
Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48
-
(2007)
Circulation
, vol.116
, pp. 39-48
-
-
Fox, C.S.1
Massaro, J.M.2
Hoffmann, U.3
-
34
-
-
0023807047
-
Low-density lipoprotein subclass patterns and risk of myocardial infarction
-
Austin MA, Breslow JL, Hennekens CH, et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917-1921
-
(1988)
JAMA
, vol.260
, pp. 1917-1921
-
-
Austin, M.A.1
Breslow, J.L.2
Hennekens, C.H.3
-
35
-
-
17144380822
-
The metabolic syndrome
-
RB, et al. Impact of impaired fasting
-
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; RB, et al. Impact of impaired fasting 365: 1415-1428
-
(2005)
Lancet
, vol.365
, pp. 1415-1428
-
-
Eckel, R.H.1
Grundy, S.M.2
Zimmet, P.Z.3
-
36
-
-
9444285816
-
Dyslipidemia and the metabolic syndrome
-
Bloomgarden ZT. Dyslipidemia and the metabolic syndrome. Diabetes Care 2004; 27: 3009-3016
-
(2004)
Diabetes Care
, vol.27
, pp. 3009-3016
-
-
Bloomgarden, Z.T.1
-
37
-
-
84910110212
-
The insulin resistance syndrome: Impact on lipoprotein metabolism and atherothrombosis
-
Ginsberg HN, Huang LS. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis. J Cardiovasc Risk 2000; 7: 325-331
-
(2000)
J Cardiovasc Risk
, vol.7
, pp. 325-331
-
-
Ginsberg, H.N.1
Huang, L.S.2
-
38
-
-
31744450497
-
Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia
-
Kolovou GD, Anagnostopoulou K, Pilatis ND, et al. Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia. Vasc Health Risk Manag 2005; 1: 155-161
-
(2005)
Vasc Health Risk Manag
, vol.1
, pp. 155-161
-
-
Kolovou, G.D.1
Anagnostopoulou, K.2
Pilatis, N.D.3
-
39
-
-
0027502421
-
Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B
-
Chait A, Brazg RL, Tribble DL, et al. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 1993; 94: 350-356
-
(1993)
Am J Med
, vol.94
, pp. 350-356
-
-
Chait, A.1
Brazg, R.L.2
Tribble, D.L.3
-
40
-
-
0031890581
-
Atherogenic, dense low-density lipoproteins: Pathophysiology and new therapeutic approaches
-
Chapman MJ, Gué rin M, Bruckert E. Atherogenic, dense low-density lipoproteins: pathophysiology and new therapeutic approaches. Eur Heart J 1998; 19 Suppl. A: A24-30
-
(1998)
Eur Heart J
, vol.19
, Issue.SUPPL. A
-
-
Chapman, M.J.1
Guerin, M.2
Bruckert, E.3
-
41
-
-
0026682450
-
Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size
-
Tribble DL, Holl LG, Wood PD, et al. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992; 93: 189-199
-
(1992)
Atherosclerosis
, vol.93
, pp. 189-199
-
-
Tribble, D.L.1
Holl, L.G.2
Wood, P.D.3
-
42
-
-
0025977492
-
Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects
-
De Graaf J, Hak-Lemmers HL, Hectors MP, et al. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991; 11: 298-306
-
(1991)
Arterioscler Thromb
, vol.11
, pp. 298-306
-
-
De Graaf, J.1
Hak-Lemmers, H.L.2
Hectors, M.P.3
-
43
-
-
0242300697
-
The coming of age of the metabolic syndrome
-
Alexander CM. The coming of age of the metabolic syndrome. Diabetes Care 2003; 26: 3180-3181
-
(2003)
Diabetes Care
, vol.26
, pp. 3180-3181
-
-
Alexander, C.M.1
-
44
-
-
33645089715
-
Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men
-
St-Pierre AC, Cantin B, Dagenais GR, et al. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men. Am J Cardiol 2006; 97: 997-1001
-
(2006)
Am J Cardiol
, vol.97
, pp. 997-1001
-
-
St-Pierre, A.C.1
Cantin, B.2
Dagenais, G.R.3
-
45
-
-
33644876621
-
Apolipoprotein B versus non-high-density lipoprotein cholesterol: And the winner is
-
Sniderman AD. Apolipoprotein B versus non-high-density lipoprotein cholesterol: and the winner is... Circulation 2005; 112: 3366-3367
-
(2005)
Circulation
, vol.112
, pp. 3366-3367
-
-
Sniderman, A.D.1
-
46
-
-
33644874294
-
Weighing in before the fight: Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy
-
Denke MA. Weighing in before the fight: low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy. Circulation 2005; 112: 3368-3370
-
(2005)
Circulation
, vol.112
, pp. 3368-3370
-
-
Denke, M.A.1
-
47
-
-
2142771357
-
Non-HDL cholesterol versus apolipoprotein B in diabetic dyslipoproteinemia: Alternatives and surrogates versus the real thing
-
Sniderman AD. Non-HDL cholesterol versus apolipoprotein B in diabetic dyslipoproteinemia: alternatives and surrogates versus the real thing. Diabetes Care 2003; 26: 2207-2208
-
(2003)
Diabetes Care
, vol.26
, pp. 2207-2208
-
-
Sniderman, A.D.1
-
48
-
-
0037069434
-
Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Re-vascularization Investigation (BARI).; Bypass Angioplasty Revasculari-zation Investigation
-
Nov 12
-
Bittner V, Hardison R, Kelsey SF, et al. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Re-vascularization Investigation (BARI).; Bypass Angioplasty Revasculari-zation Investigation. Circulation 2002 Nov 12; 106 (20): 2537-2542
-
(2002)
Circulation
, vol.106
, Issue.20
, pp. 2537-2542
-
-
Bittner, V.1
Hardison, R.2
Kelsey, S.F.3
-
49
-
-
3342958811
-
Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes
-
Jiang R, Schulze MB, Li T, et al. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 2004; 27: 1991-1997
-
(2004)
Diabetes Care
, vol.27
, pp. 1991-1997
-
-
Jiang, R.1
Schulze, M.B.2
Li, T.3
-
50
-
-
23044485065
-
Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes
-
Liu J, Sempos C, Donahue RP, et al. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes. Diabetes Care 2005; 28: 1916-1921
-
(2005)
Diabetes Care
, vol.28
, pp. 1916-1921
-
-
Liu, J.1
Sempos, C.2
Donahue, R.P.3
-
51
-
-
22244446183
-
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women
-
Ridker PM, Rifai N, Cook NR, et al. Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005; 294: 326-333
-
(2005)
JAMA
, vol.294
, pp. 326-333
-
-
Ridker, P.M.1
Rifai, N.2
Cook, N.R.3
-
52
-
-
33750527116
-
Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease
-
Liu J, Sempos CT, Donahue RP, et al. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 2006; 98: 1363-1368
-
(2006)
Am J Cardiol
, vol.98
, pp. 1363-1368
-
-
Liu, J.1
Sempos, C.T.2
Donahue, R.P.3
-
53
-
-
0034912018
-
Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality
-
Cui Y, Blumenthal RS, Flaws JA, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 2001; 161: 1413-1419
-
(2001)
Arch Intern Med
, vol.161
, pp. 1413-1419
-
-
Cui, Y.1
Blumenthal, R.S.2
Flaws, J.A.3
-
54
-
-
35848958806
-
Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese
-
Chien KL, Hsu HC, Su TC, et al. Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese. J Lipid Res 2007; 48: 2499-2505
-
(2007)
J Lipid Res
, vol.48
, pp. 2499-2505
-
-
Chien, K.L.1
Hsu, H.C.2
Su, T.C.3
-
55
-
-
0037479469
-
Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: The strong heart study
-
Lu W, Resnick HE, Jablonski KA, et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care 2003; 26: 16-23
-
(2003)
Diabetes Care
, vol.26
, pp. 16-23
-
-
Lu, W.1
Resnick, H.E.2
Jablonski, K.A.3
-
56
-
-
33644873843
-
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men
-
Pischon T, Girman CJ, Sacks FM, et al. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005; 112: 3375-3383
-
(2005)
Circulation
, vol.112
, pp. 3375-3383
-
-
Pischon, T.1
Girman, C.J.2
Sacks, F.M.3
-
57
-
-
34547876797
-
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women
-
Ingelsson E, Schaefer EJ, Contois JH, et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 2007; 298: 776-785
-
(2007)
JAMA
, vol.298
, pp. 776-785
-
-
Ingelsson, E.1
Schaefer, E.J.2
Contois, J.H.3
-
58
-
-
58249086417
-
Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk
-
Robinson JG, Wang S, Smith BJ, et al. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol 2009; 53: 316-322
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 316-322
-
-
Robinson, J.G.1
Wang, S.2
Smith, B.J.3
-
59
-
-
23744501476
-
Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes?
-
Shepherd J. Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes? Atheroscler Suppl 2005; 6: 15-19
-
(2005)
Atheroscler Suppl
, vol.6
, pp. 15-19
-
-
Shepherd, J.1
-
60
-
-
34548433987
-
Clinical practice: Hypertriglyceridemia
-
Sep 6
-
Brunzell JD. Clinical practice: hypertriglyceridemia. N Engl J Med 2007 Sep 6; 357 (10): 1009-1017
-
(2007)
N Engl J Med
, vol.357
, Issue.10
, pp. 1009-1017
-
-
Brunzell, J.D.1
-
61
-
-
0037069339
-
Low-density lipoprotein, non-high-density lipoprotein, and apolipo-protein B as targets of lipid-lowering therapy
-
Grundy SM. Low-density lipoprotein, non-high-density lipoprotein, and apolipo-protein B as targets of lipid-lowering therapy. Circulation 2002; 106: 2526-2529
-
(2002)
Circulation
, vol.106
, pp. 2526-2529
-
-
Grundy, S.M.1
-
62
-
-
48849112223
-
Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: The MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial
-
Ballantyne CM, Raichlen JS, Cain VA. Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial. J Am Coll Cardiol 2008; 52: 626-632
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 626-632
-
-
Ballantyne, C.M.1
Raichlen, J.S.2
Cain, V.A.3
-
63
-
-
0032554686
-
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)
-
Pedersen TR, Olsson AG, Faergeman O, et al. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation 1998; 97: 1453-1460
-
(1998)
Circulation
, vol.97
, pp. 1453-1460
-
-
Pedersen, T.R.1
Olsson, A.G.2
Faergeman, O.3
-
64
-
-
0037834856
-
Non-high density lipoprotein cholesterol and coronary events during long-term statin treatment
-
Athyros VG, Papageorgiou AA, Symeonidis AN, et al. Non-high density lipoprotein cholesterol and coronary events during long-term statin treatment. Atherosclerosis 2003; 168: 397-398
-
(2003)
Atherosclerosis
, vol.168
, pp. 397-398
-
-
Athyros, V.G.1
Papageorgiou, A.A.2
Symeonidis, A.N.3
-
65
-
-
50649115698
-
Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. insights from the incremental decrease in end-points through aggressive lipid-lowering trial (IDEAL)
-
Lipid-Lowering Study Group
-
Holme I, Cater NB, Faergeman O, et al. Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. insights from the incremental decrease in end-points through aggressive lipid-lowering trial (IDEAL). Lipid-Lowering Study Group. Ann Med 2008; 40: 456-464
-
(2008)
Ann Med
, vol.40
, pp. 456-464
-
-
Holme, I.1
Cater, N.B.2
Faergeman, O.3
|